van der Graaf WTA - Search Results

1

Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Oude Nijhuis CSM, Vellenga E, Daenen SMGJ, van der Graaf WTA, Gietema JA, Groen HJM, Kamps WA, de Bont ESJM. Oude Nijhuis CSM, et al. Among authors: van der graaf wta. Intensive Care Med. 2003 Dec;29(12):2157-2161. doi: 10.1007/s00134-003-2026-2. Epub 2003 Oct 16. Intensive Care Med. 2003. PMID: 14569424 Clinical Trial.

2

In vitro and in vivo modulation of multi-drug resistance with amiodarone.

van der Graaf WT, de Vries EG, Uges DR, Nanninga AG, Meijer C, Vellenga E, Mulder PO, Mulder NH. van der Graaf WT, et al. Int J Cancer. 1991 Jun 19;48(4):616-22. doi: 10.1002/ijc.2910480422. Int J Cancer. 1991. PMID: 1646180

3

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.

Veldhuis GJ, Willemse PH, Sleijfer DT, van der Graaf WT, Groen HJ, Limburg PC, Mulder NH, de Vries EG. Veldhuis GJ, et al. J Clin Oncol. 1995 Oct;13(10):2585-93. doi: 10.1200/JCO.1995.13.10.2585. J Clin Oncol. 1995. PMID: 7595711 Clinical Trial.

4

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

Gietema JA, Veldhuis GJ, Guchelaar HJ, Willemse PH, Uges DR, Cats A, Boonstra H, van der Graaf WT, Sleijfer DT, de Vries EG, et al. Gietema JA, et al. Br J Cancer. 1995 Jun;71(6):1302-7. doi: 10.1038/bjc.1995.252. Br J Cancer. 1995. PMID: 7779728 Free PMC article. Clinical Trial.

5

Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.

van der Graaf WT, de Vries EG, Timmer-Bosscha H, Meersma GJ, Mesander G, Vellenga E, Mulder NH. van der Graaf WT, et al. Cancer Res. 1994 Oct 15;54(20):5368-73. Cancer Res. 1994. PMID: 7923167

6

The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.

Ham SJ, Hoekstra HJ, van der Graaf WT, Kamps WA, Molenaar WM, Schraffordt Koops H. Ham SJ, et al. J Clin Oncol. 1996 Feb;14(2):490-6. doi: 10.1200/JCO.1996.14.2.490. J Clin Oncol. 1996. PMID: 8636762

7

The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.

de Graaf H, Mulder NH, Willemse PH, van der Graaf WT, Sleijfer DT, Zijlstra JG, Elias M, Sibinga CT, Vellenga E, de Vries EG. de Graaf H, et al. Anticancer Res. 1995 Nov-Dec;15(6B):2851-6. Anticancer Res. 1995. PMID: 8669878

8

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.

de Jong RS, Mulder NH, Uges DR, Kaul S, Winograd B, Sleijfer DTh, Groen HJ, Willemse PH, van der Graaf WT, de Vries EG. de Jong RS, et al. Br J Cancer. 1997;75(11):1660-6. doi: 10.1038/bjc.1997.282. Br J Cancer. 1997. PMID: 9184183 Free PMC article. Clinical Trial.

9

Magnesium and phosphorus.

Gietema JA, Meinardi MT, van der Graaf WT, Uges DR, Sleijfer DT. Gietema JA, et al. Lancet. 1998 Oct 31;352(9138):1476. doi: 10.1016/s0140-6736(05)61307-4. Lancet. 1998. PMID: 9808023 No abstract available.

10

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.

de Jong RS, Mulder NH, Uges DR, Sleijfer DT, Höppener FJ, Groen HJ, Willemse PH, van der Graaf WT, de Vries EG. de Jong RS, et al. Br J Cancer. 1999 Feb;79(5-6):882-7. doi: 10.1038/sj.bjc.6690141. Br J Cancer. 1999. PMID: 10070885 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters